Mode
Text Size
Log in / Sign up
N/A Completed N=56 Randomized Other

Mobile HIV Prevention App for Black Women

Mobile Phone Use · HIV · Stigma, Social
Source: ClinicalTrials.gov NCT05080972 ↗
Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Retention Rate — 20; 24 Participants

Summary

Black women have a significantly higher risk of acquiring HIV compared to their non-Black counterparts. The purpose of this study is to refine and test a mobile HIV Prevention and Reproductive Health app developed specifically for Black women.

Outcome Measures

OutcomeResultp-value
PRIMARY
Retention Rate
20; 24 —
PRIMARY
App User Retention Rate
70.03 —
PRIMARY
System Usability Scale (SUS)
63.25 —
PRIMARY
Impact Scale
4.19 —
PRIMARY
Perceived Usefulness (PU) Scale
3.54 —
PRIMARY
Perceived Ease of Use (PEOU) Scale
3.69 —
SECONDARY
Number of Home Test Kits Ordered by Participants.
3 —
SECONDARY
Number of Participants Indicating Intention to Start PrEP
8; 12; 11; 9; 5; 5 —
SECONDARY
Number of Participants Who Agreed With Statements About PrEP Initiation
1; 2; 19; 18; 6; 8 —
SECONDARY
Number of Participant's Who Initiated PrEP Treatment
0; 0 —
SECONDARY
Number of Enrolled Participants by Recruiting Source
21; 16; 0; 0; 1; 0 —
SECONDARY
Number of Participants Reporting Smartphone Ownership
28; 28 —

Eligibility Criteria

Inclusion Criteria

  • 18-44 years of age
  • Self-identify as Black
  • Assigned female at birth and identify as female
  • Individuals who qualify for Pre-Exposure Prophylaxis (PrEP) based on the Centers for Disease Control (CDC) criteria (for residence in high HIV incidence areas-reside in Fulton, Cobb, Gwinnett, or Dekalb counties)
  • Sexually active within the last 6 months
  • HIV-negative
  • Owner of an Android or IOS smartphone

Exclusion Criteria

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Cognitively impaired or Individuals with Impaired Decision-Making Capacity
  • Individuals who are not able to clearly understand English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05080972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search